India, June 10 -- Shares of Evogene Ltd. (EVGN) are surging nearly 133 percent after the Israeli computational biology company announced the completion of its generative AI foundation model developed in collaboration with Google Cloud, affiliated to tech major Alphabet Inc. (GOOG,GOOGL).
The new model, version 1.0, for small molecule design, expands the existing capabilities of ChemPass AI, Evogene's tech-engine for small molecule discovery and optimization.
Evogene also announced that development is already underway on version 2.0 of its generative AI foundation model, with a focus on enhanced flexibility for multi-parameter optimization.
The new generative AI foundation is built on a large dataset of approximately 38 billion molecular ...